Biostar Pharmaceuticals Analysis

Biostar Pink Sheet Analysis Notes

The company has price-to-book (P/B) ratio of 0.01. Some equities with similar Price to Book (P/B) outperform the market in the long run. Biostar Pharmaceuticals had not issued any dividends in recent years. The entity had 1:7 split on the 5th of February 2016. Biostar Pharmaceuticals, Inc. develops, manufactures, and markets over-the-counter and prescription pharmaceutical products for various diseases and conditions in the Peoples Republic of China. The company was incorporated in 2007 and is headquartered in Xianyang, the Peoples Republic of China. Biostar Pharmaceuticals operates under Pharmaceuticals And Biosciences classification in the United States and is traded on OTC Exchange. It employs 200 people.The quote for Biostar Pharmaceuticals is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. For more info on Biostar Pharmaceuticals please contact Ronghua Wang at 86 29 3368 6638 or go to https://biostarpharmaceuticals.com.

Biostar Pharmaceuticals Investment Alerts

Biostar Market Capitalization

The company currently falls under 'Nano-Cap' category with a current market capitalization of 94. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Biostar Pharmaceuticals's market, we take the total number of its shares issued and multiply it by Biostar Pharmaceuticals's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Biostar Profitablity

The company has Profit Margin (PM) of 2.94 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is normal as compared to the sector avarege. Similarly, it shows Operating Margin (OM) of 8.76 %, which suggests for every 100 dollars of sales, it generated a net operating income of $8.76.

Biostar Pharmaceuticals Outstanding Bonds

Pink Sheet analysis is the technique used by a trader or investor to examine and evaluate how Biostar Pharmaceuticals prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Biostar shares will generate the highest return on investment. We also built our pink sheet analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Pink Sheet such as Biostar Pharmaceuticals. By using and applying Biostar Pink Sheet analysis, traders can create a robust methodology for identifying Biostar entry and exit points for their positions.

Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.

If you are still planning to invest in Biostar Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Biostar Pharmaceuticals' history and understand the potential risks before investing.